These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 11275363)
1. Taxol-induced cell cycle arrest and apoptosis: dose-response relationship in lung cancer cells of different wild-type p53 status and under isogenic condition. Das GC; Holiday D; Gallardo R; Haas C Cancer Lett; 2001 Apr; 165(2):147-53. PubMed ID: 11275363 [TBL] [Abstract][Full Text] [Related]
3. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Bacus SS; Gudkov AV; Lowe M; Lyass L; Yung Y; Komarov AP; Keyomarsi K; Yarden Y; Seger R Oncogene; 2001 Jan; 20(2):147-55. PubMed ID: 11313944 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Taxol-induced cell death are concentration dependent. Torres K; Horwitz SB Cancer Res; 1998 Aug; 58(16):3620-6. PubMed ID: 9721870 [TBL] [Abstract][Full Text] [Related]
5. Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest. Roth W; Wagenknecht B; Grimmel C; Dichgans J; Weller M Br J Cancer; 1998; 77(3):404-11. PubMed ID: 9472635 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines. Gibb RK; Taylor DD; Wan T; O'Connor DM; Doering DL; Gerçel-Taylor C Gynecol Oncol; 1997 Apr; 65(1):13-22. PubMed ID: 9103385 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel sensitivity correlates with p53 status and DNA fragmentation, but not G2/M accumulation. Rakovitch E; Mellado W; Hall EJ; Pandita TK; Sawant S; Geard CR Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1119-24. PubMed ID: 10421546 [TBL] [Abstract][Full Text] [Related]
8. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment. Fan S; Cherney B; Reinhold W; Rucker K; O'Connor PM Clin Cancer Res; 1998 Apr; 4(4):1047-54. PubMed ID: 9563901 [TBL] [Abstract][Full Text] [Related]
9. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Wahl AF; Donaldson KL; Fairchild C; Lee FY; Foster SA; Demers GW; Galloway DA Nat Med; 1996 Jan; 2(1):72-9. PubMed ID: 8564846 [TBL] [Abstract][Full Text] [Related]
10. Molecular effects of taxol and caffeine on pancreatic cancer cells. Gururajanna B; Al-Katib AA; Li YW; Aranha O; Vaitkevicius VK; Sarkar FH Int J Mol Med; 1999 Nov; 4(5):501-7. PubMed ID: 10534572 [TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard. Bhatia U; Danishefsky K; Traganos F; Darzynkiewicz Z Clin Cancer Res; 1995 Aug; 1(8):873-80. PubMed ID: 9816057 [TBL] [Abstract][Full Text] [Related]
12. Radiosensitization in sarcoma cell lines with a p53 missense mutation correlates with prevention of irradiation G2/M arrest but not with induction of apoptosis. Bache M; Oehlmann S; Meye A; Bartel F; Kappler M; Würl P; Schmidt H; Rath FW; Dunst J; Taubert H Oncol Rep; 2001; 8(5):1007-11. PubMed ID: 11496306 [TBL] [Abstract][Full Text] [Related]
13. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells. Choi YH; Yoo YH Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313 [TBL] [Abstract][Full Text] [Related]
14. Schedule-dependent cytotoxicity of SN-38 in p53 wild-type and mutant colon adenocarcinoma cell lines. te Poele RH; Joel SP Br J Cancer; 1999 Dec; 81(8):1285-93. PubMed ID: 10604724 [TBL] [Abstract][Full Text] [Related]
15. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe. Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750 [TBL] [Abstract][Full Text] [Related]
17. Failure of taxol-based combination chemotherapy for malignant glioma cannot be overcome by G2/M checkpoint abrogators or altering the p53 status. Borbé R; Rieger J; Weller M Cancer Chemother Pharmacol; 1999; 44(3):217-27. PubMed ID: 10453723 [TBL] [Abstract][Full Text] [Related]
18. The bioreductive agent RH1 and gamma-irradiation both cause G2/M cell cycle phase arrest and polyploidy in a p53-mutated human breast cancer cell line. Kim JY; Kim CH; Stratford IJ; Patterson AV; Hendry JH Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):376-85. PubMed ID: 14751506 [TBL] [Abstract][Full Text] [Related]
19. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Frankel A; Buckman R; Kerbel RS Cancer Res; 1997 Jun; 57(12):2388-93. PubMed ID: 9192815 [TBL] [Abstract][Full Text] [Related]
20. Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis. Vikhanskaya F; Vignati S; Beccaglia P; Ottoboni C; Russo P; D'Incalci M; Broggini M Exp Cell Res; 1998 May; 241(1):96-101. PubMed ID: 9633517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]